Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Clinical Ophthalmic Oncology -

Clinical Ophthalmic Oncology

Retinal Tumors
Buch | Hardcover
XII, 172 Seiten
2019 | 3rd ed. 2019
Springer International Publishing (Verlag)
978-3-030-04112-0 (ISBN)
CHF 194,70 inkl. MwSt
  • Lieferbar
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
Zu diesem Artikel existiert eine Nachauflage

Written by internationally renowned experts, the 3rd edition of this six volume textbook provides detailed practical guidance and advice on the diagnosis and management of the complete range of ocular cancers. Supplying the reader with state-of-the-art knowledge required in order to identify these cancers early and to treat them as effectively as possible, this book is divided into six volumes: Basic Principles, Eyelid and Conjunctival Tumors, Orbital Tumors, Uveal Tumors, Retinal Tumors, and Retinoblastoma. The information presented enables readers to provide effective patient care using the latest knowledge on ophthalmic oncology and to verify diagnostic conclusions based on comparison with numerous full-color clinical photographs from the authors' private collections, histopathologic microphotographs, imaging studies, and crisp illustrations. 

Clinical Ophthalmic Oncology's clinically focused and user-friendly format allows for rapid retrieval of information in daily practice and is written for residents, fellows, and any physician involved in the care of patients with ocular or orbital malignancies. Additionally, this edition adds several hundred new images to improve comprehension of procedures and techniques. This volume provides diagnosis and therapy for retinal tumors, including vitreoretinal lymphoma and paraneoplastic disorders.

Arun Singh, MD, is Director of the Cole Eye Institute at Cleveland Clinic in the Department of Ophthalmic Oncology. He is also the Series Editor for Springer's Essentials in Ophthalmology series and was the former Editor for The British Journal of Ophthalmology and is the current Editor of Ocular Oncology and Pathology. Bertil Damato, MD, PhD, is Professor of Ophthalmology and Radiation Oncology and Director of the Ocular Oncology Service at the University of California, San Francisco. Until 2013, he was Consultant Ophthalmologist at the Royal Liverpool University Hospital, where he was Director of the Ocular Oncology Service, which he established in 1993. Dr. Damato has published more than 200 peer-reviewed articles, 68 reviews, 75 book chapters and 6 books, one as single author.

1. Classification of Retinal and Retinal Pigment Epithelium Tumors.- 2. Coats' Disease.- 3. Retinal Vascular Tumors.- 4. Retinal Astrocytic Tumors.- 5. Retinal Pigment Epithelial Tumors.- 6. Tumors of the Ciliary Epithelium.- 7. Primary Central Nervous System and Retinal Lymphoma.- 8. Retinal Metastatic Tumors.- 9. Neuro-oculocutaneous Syndromes (Phakomatoses).- 10. Ocular Paraneoplastic Diseases.          

Erscheinungsdatum
Zusatzinfo XII, 172 p. 76 illus., 69 illus. in color.
Verlagsort Cham
Sprache englisch
Maße 178 x 254 mm
Gewicht 719 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Augenheilkunde
Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Schlagworte Cancer Staging • clinical ophthalmic oncology • complications • immunology • Retinal tumors • targeted therapy • Tumor Associated Diseases
ISBN-10 3-030-04112-3 / 3030041123
ISBN-13 978-3-030-04112-0 / 9783030041120
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich